|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
| |
 |
| Xanthus Pharmaceuticals |
OBP IV |
(Acquired by Antisoma plc (LSE: ASM)
Cambridge, MA and London, UK
www.antisoma.com
Antisoma is a biopharmaceutical company specializing in the development and commercialization of novel products for the treatment of cancer.
|
|
| |
|
|
|
|
|
